<?xml version="1.0" encoding="UTF-8"?>
<ref id="fsn32021-bib-0030">
 <mixed-citation publication-type="journal" id="fsn32021-cit-0030">
  <string-name>
   <surname>Montazeri</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Sharif</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Sarvi</surname>, 
   <given-names>S.</given-names>
  </string-name>, 
  <string-name>
   <surname>Mehrzadi</surname>, 
   <given-names>S.</given-names>
  </string-name>, 
  <string-name>
   <surname>Ahmadpour</surname>, 
   <given-names>E.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Daryani</surname>, 
   <given-names>A.</given-names>
  </string-name> (
  <year>2017</year>). 
  <article-title>A systematic review of in vitro and in vivo activities of anti‐toxoplasma drugs and compounds (2006–2016)</article-title>. 
  <source xml:lang="en">Frontiers in Microbiology</source>, 
  <volume>8</volume>, 
  <fpage>25</fpage>
  <pub-id pub-id-type="doi">10.3389/fmicb.2017.00025</pub-id>
  <pub-id pub-id-type="pmid">28163699</pub-id>
 </mixed-citation>
</ref>
